Atrás
Precio Antengene Corporation Limited (06996.HK)
Gráfico del Precio de Acciones 06996.HK
ANTENGENE-B (06996.HK)
Antengene Corporation Limited
HK$3.6
-1.09%
$-0.04
Mercado Regular: Jan 21, 16:03:49 HKT
Estadísticas clave
Cierre Anterior
$3.7
Precio de apertura
$3.64
Rango del día
$3.54 - $3.68
Rango de 52 semanas
$0.69 - $8.16
Volumen
2.5M
Volumen promedio
2.4M
EPS (TTM)
-0.40
Rendimiento de dividendos
--
Cap. de mercado
$2.1B
¿Qué es ANTENGENE-B?
Antengene Corp. Ltd. operates as a clinical-stage Asia-Pacific biopharmaceutical company. The company is headquartered in Shanghai, Shanghai and currently employs 152 full-time employees. The company went IPO on 2020-11-20. The firm is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The firm's products include ATG-010 (selinexor), treating for relapsed/refractory multiple myeloma, relapsed/refractory diffuse large B-cell lymphoma and non-small cell lung cancer and ATG-008 (onatasertib), treating for hepatocellular carcinoma and non-small cell lung cancer. The firm mainly conducts its business in Asia-Pacific.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved
